Routine Optimization Does Not Necessarily Require A Disclosure Of Ranges Under The Results-Effective Variable Doctrine – Pfizer V. Sanofi, No. 19-1871 (Fed Cir 2024) - Patent

The results-effective variable doctrine is a caselaw principle where prior art disclosing the "general conditions of a claim" invokes a presumption of obviousness...

Related Keywords

,Pfizer ,Pasteur Inc ,Sk Chemicals Co ,Federal Circuit ,Mondaq ,Routine Optimization Does Not Necessarily Requirea Disclosure Of Ranges Under The Results Effective Variable Doctrine X2013 Pfizerv Sanofi ,O 19 1871 Fed Cir 2024 ,Intellectual Property ,Patent ,